135 related articles for article (PubMed ID: 10111726)
1. A targeted review of vancomycin use.
Piquette RK
Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
Fletcher CV; Giese RM; Rodman JH
Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
[TBL] [Abstract][Full Text] [Related]
3. The effect of pharmacy intervention on aminoglycoside costs.
Tsuyuki RT; Nakagawa RS
Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
[TBL] [Abstract][Full Text] [Related]
4. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
Hayman JN; Sbravati EC
Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
[TBL] [Abstract][Full Text] [Related]
5. Cefoxitin use review.
Lazor-Bajcar JM
Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924
[TBL] [Abstract][Full Text] [Related]
6. A strategy to reduce drug expenditures with a drug utilization review program.
Hoffmann RP
Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
[TBL] [Abstract][Full Text] [Related]
7. A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.
Dranitsaris G; Pilla NJ; McGreer A
Can J Hosp Pharm; 1994 Apr; 47(2):59-64. PubMed ID: 10134128
[TBL] [Abstract][Full Text] [Related]
8. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
Briceland LL; Quintiliani R; Nightingale CH
Am J Hosp Pharm; 1988 Jan; 45(1):122-5. PubMed ID: 3348224
[TBL] [Abstract][Full Text] [Related]
10. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
Goff D; Thornton J
Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
[TBL] [Abstract][Full Text] [Related]
11. Intravenous vancomycin usage in a tertiary care hospital.
Madsen M; Taylor GD
Can J Hosp Pharm; 1989 Aug; 42(4):153-6. PubMed ID: 10294300
[TBL] [Abstract][Full Text] [Related]
12. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients.
Hing WC; Bek SJ; Lin RT; Li SC
J Clin Pharm Ther; 2004 Aug; 29(4):359-65. PubMed ID: 15271103
[TBL] [Abstract][Full Text] [Related]
13. Prospective vancomycin audit in Auckland healthcare hospitals.
Drinkovic D; Taylor SL; Pottumarthy S; Morris AJ
N Z Med J; 1999 Sep; 112(1095):336-9. PubMed ID: 10553935
[TBL] [Abstract][Full Text] [Related]
14. An approach to cost-effective antibiotic utilization.
Venezio FR; Waitley DW
Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin use in 2 Ontario tertiary care hospitals: a survey.
Kwan T; Lin F; Ngai B; Loeb M
Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867
[TBL] [Abstract][Full Text] [Related]
16. Concurrent antibiotic-use review in a small hospital.
Kerns MP; Meyer GE
Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
[TBL] [Abstract][Full Text] [Related]
17. Controlling moxalactam and cefotaxime use with a target drug program.
Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
[TBL] [Abstract][Full Text] [Related]
18. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
[TBL] [Abstract][Full Text] [Related]
19. Controlling the costs of antibiotic resistance.
North D
Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
